TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 3 | 1 | 3 | -2 | -1 | 3 | 27 | 30 | 47 | 17 |
| P | %wins | 67 | 67 | 33 | 33 | 33 | 100 | 56 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/31/14 17:53 | 7/29/14 | IMDZ | Immune Design Corp. | DE | Health | Drug | Pharmaceutical Preparations | Versant Venture Capital Iii, L.P. | CA | T | P.d | 2,800 | 12.00 | 6 | 233 | 12 | 2,208 | D | 0 | 0 | 1 | -2 | 131 | 108 | 66 | ||||||||
2/20/14 15:01 | 2/18/14 | FLXN | Flexion Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Versant Venture Capital Iii, L.P. | CA | T | P.d | 4,000 | 13.00 | 7 | 308 | 4 | 8,923 | M | 2 | 0 | 8 | 31 | -15 | -7 | 54 | ||||||||
8/10/10 14:12 | 8/6/10 | TSRX | Trius Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Versant Venture Capital Iii, L.P. | CA | T | P.d | 4,573 | 5.00 | 3 | 915 | 39 | 3,236 | I | -9 | -5 | -12 | -19 | -36 | -12 | 21 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |